Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 4052846, 10 pages
http://dx.doi.org/10.1155/2016/4052846
Research Article

The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City

1Division of Urology, Department of Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan
2Department and Graduate Institute of Aquaculture, National Kaohsiung Marine University, Kaohsiung, Taiwan
3Department of Oceanography, National Sun Yat-sen University, Kaohsiung 804, Taiwan
4Department of Aquaculture, National Pingtung University of Science and Technology, Pingtung, Taiwan
5Department of Health Risk Management, China Medical University, Taichung, Taiwan
6Asia-Pacific Biotech Developing Inc., Kaohsiung, Taiwan
7Graduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan
8Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan
9Cancer Biology and Drug Discovery Ph.D. Program, College of Medicine, China Medical University, Taichung, Taiwan
10Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan

Received 18 August 2016; Accepted 7 November 2016

Academic Editor: Heiko Reutter

Copyright © 2016 Chiang-Ting Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA: Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Hirao, W.-J. Kim, and K. Fujimoto, “Environmental factors promoting bladder cancer,” Current Opinion in Urology, vol. 19, no. 5, pp. 494–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Cheng, D. D. Davison, J. Adams et al., “Biomarkers in bladder cancer: translational and clinical implications,” Critical Reviews in Oncology/Hematology, vol. 89, no. 1, pp. 73–111, 2014. View at Publisher · View at Google Scholar
  4. G. Lopez-Abente, N. Aragones, R. Ramis et al., “Municipal distribution of bladder cancer mortality in Spain: possible role of mining and industry,” BMC Public Health, vol. 6, no. 1, article 17, 1 page, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Taiwan Cancer Registry Annual Report, Health Promotion Administration, Ministry of Health and Welfare, Taipei City, Taiwan, 2012.
  6. L. A. Kiemeney, S. Thorlacius, P. Sulem et al., “Sequence variant on 8q24 confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 40, no. 11, pp. 1307–1312, 2008. View at Publisher · View at Google Scholar
  7. X. Wu, Y. Ye, L. A. Kiemeney et al., “Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 41, no. 9, pp. 991–995, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Rothman, M. Garcia-Closas, N. Chatterjee et al., “A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci,” Nature Genetics, vol. 42, no. 11, pp. 978–984, 2010. View at Publisher · View at Google Scholar
  9. L. A. Kiemeney, P. Sulem, S. Besenbacher et al., “A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer,” Nature Genetics, vol. 42, no. 5, pp. 415–419, 2010. View at Publisher · View at Google Scholar
  10. T. Rafnar, S. H. Vermeulen, P. Sulem et al., “European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene,” Human Molecular Genetics, vol. 20, no. 21, pp. 4268–4281, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Garcia-Closas, Y. Ye, N. Rothman et al., “A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3,” Human Molecular Genetics, vol. 20, no. 21, pp. 4282–4289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Gago-Dominguez, X. Jiang, D. V. Conti et al., “Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study,” Carcinogenesis, vol. 32, no. 2, pp. 197–202, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. M. C. Stern, D. Van Den Berg, J.-M. Yuan et al., “Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 11, pp. 3057–3061, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Wang, H. Chu, F. Yan et al., “Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population,” Carcinogenesis, vol. 32, no. 6, pp. 872–875, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Ma, Q. Hu, Z. Chen et al., “Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a chinese population,” Molecular Carcinogenesis, vol. 52, no. 11, pp. 916–921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Wang, J. Tang, M. Wang, L. Yuan, and Z. Zhang, “Genetic variation in PSCA and bladder cancer susceptibility in a chinese population,” Carcinogenesis, vol. 31, no. 4, pp. 621–624, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Wang, M. Wang, W. Zhang et al., “Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population,” Carcinogenesis, vol. 30, no. 6, pp. 991–996, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Schäfer, A. Gschwind, and A. Ullrich, “Multiple G-protein-coupled receptor signals converge on the epidermal growth factor receptor to promote migration and invasion,” Oncogene, vol. 23, no. 4, pp. 991–999, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-L. Tang, Y. Wang, D.-L. Li, J. Luo, and M.-Y. Liu, “Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets,” Acta Pharmacologica Sinica, vol. 33, no. 3, pp. 363–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. R. R. Resende and A. Adhikari, “Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation,” Cell Communication and Signaling, vol. 7, article 20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. I. Bonner, N. J. Buckley, A. C. Young, and M. R. Brann, “Identification of a family of muscarinic acetylcholine receptor genes,” Science, vol. 237, no. 4814, pp. 527–532, 1987. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman, “Muscarinic receptors and ligands in cancer,” American Journal of Physiology—Cell Physiology, vol. 296, no. 2, pp. C221–C232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. Fowler, D. Griffiths, and W. C. De Groat, “The neural control of micturition,” Nature Reviews Neuroscience, vol. 9, no. 6, pp. 453–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Chess-Williams, “Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional,” Autonomic and Autacoid Pharmacology, vol. 22, no. 3, pp. 133–145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Weber, H. Thiele, S. Mir et al., “Muscarinic acetylcholine receptor m3 mutation causes urinary bladder disease and a prune-belly-like syndrome,” American Journal of Human Genetics, vol. 89, no. 5, pp. 668–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Vauhkonen, T. Böhling, S. Eissa, S. Shoman, and S. Knuutila, “Can bladder adenocarcinomas be distinguished from schistosomiasis-associated bladder cancers by using array comparative genomic hybridization analysis?” Cancer Genetics and Cytogenetics, vol. 177, no. 2, pp. 153–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Karin and F. R. Greten, “NF-κB: Linking inflammation and immunity to cancer development and progression,” Nature Reviews Immunology, vol. 5, no. 10, pp. 749–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. L. R. Cardon and J. I. Bell, “Association study designs for complex diseases,” Nature Reviews Genetics, vol. 2, no. 2, pp. 91–99, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Clin and J.-C. Pairon, “Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement,” BMC Public Health, vol. 14, p. 1155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-M. Chen, W.-Y. Lin, and C.-C. Chan, “The impact of petrochemical industrialisation on life expectancy and per capita income in Taiwan: an 11-year longitudinal study,” BMC Public Health, vol. 14, no. 1, article 247, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T.-M. Chen, P.-L. Kuo, C.-H. Hsu et al., “Microsatellite in the 3′ untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression,” Human mutation, vol. 28, no. 1, p. 98, 2007. View at Google Scholar · View at Scopus
  32. Y.-M. J. Lin, S.-C. Chao, T.-M. Chen, T.-J. Lai, J.-S. Chen, and H. S. Sun, “Association of functional polymorphisms of the human tryptophan hydroxylase 2 gene with risk for bipolar disorder in Han Chinese,” Archives of General Psychiatry, vol. 64, no. 9, pp. 1015–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. C. Malbon, “G proteins in development,” Nature Reviews Molecular Cell Biology, vol. 6, no. 9, pp. 689–701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. A. C. Kruse, J. Hu, A. C. Pan et al., “Structure and dynamics of the M3 muscarinic acetylcholine receptor,” Nature, vol. 482, no. 7386, pp. 552–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. S. Valenstein, The War of The Soups and The Sparks : The Discovery of Neurotransmitters and The Dispute Over How Nerves Communicate, Columbia University Press, New York, NY, USA, 2005.
  36. P. Abrams, K.-E. Andersson, J. J. Buccafusco et al., “Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder,” British Journal of Pharmacology, vol. 148, no. 5, pp. 565–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Gutkind, E. A. Novotny, M. R. Brann, and K. C. Robbins, “Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 11, pp. 4703–4707, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Frucht, R. T. Jensen, D. Dexter, W.-L. Yang, and Y. Xiao, “Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor,” Clinical Cancer Research, vol. 5, no. 9, pp. 2532–2539, 1999. View at Google Scholar · View at Scopus
  39. W.-L. Yang and H. Frucht, “Cholinergic receptor up-regulates COX-2 expression and prostaglandin E2 production in colon cancer cells,” Carcinogenesis, vol. 21, no. 10, pp. 1789–1793, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. J.-P. Raufman, J. Shant, G. Xie et al., “Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice,” Carcinogenesis, vol. 32, no. 9, pp. 1396–1402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Narisawa, N. E. Magadia, J. H. Weisburger, and E. L. Wynder, “Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N methyl N' nitro N nitrosoguanidine in rats,” Journal of the National Cancer Institute, vol. 53, no. 4, pp. 1093–1097, 1974. View at Google Scholar · View at Scopus
  42. E. C. von Rosenvinge and J.-P. Raufman, “Muscarinic receptor signaling in colon cancer,” Cancers, vol. 3, no. 1, pp. 971–981, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Y. Lin, Y. X. Lee, S. L. Yu et al., “Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition,” Oncotarget, vol. 7, no. 16, pp. 21799–21811, 2016. View at Publisher · View at Google Scholar
  44. Y. Wang, J. Li, S. Wen et al., “CHRM3 is a novel prognostic factor of poor prognosis in patients with endometrial carcinoma,” American Journal of Translational Research, vol. 7, no. 5, pp. 902–911, 2015. View at Google Scholar · View at Scopus